Product Information
CARBIDOPA-LEVO ER 25-100 TAB is a generic product labeled by American Health Packaging, priced at $0.1117 per EA under NDC 68084028101. Its NADAC has been published 640 times since Nov 28, 2013.
FDA first approved this application on Aug 23, 2007.
Strength
25; 100 mg/1; mg/1
Manufacturer
American Health PackagingNDC
68084028101
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA077828FDA Approved
8/23/2007
On Market Since
9/1/2008
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVO ER 25-100 TAB has been published 640 times since Nov 28, 2013, and over the history we have for it it has declined 59.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1117 per EA |
|---|---|
| All-time high | $0.3892 (May 13, 2015) |
| All-time low | $0.1048 (Nov 20, 2024) |
| 52-week high | $0.1349 |
| 52-week low | $0.1101 |
| Median price | $0.2491 |
| Average price | $0.2377 |
| Largest weekly change | +35.9% (Jan 17, 2018) |
| Weeks tracked | 640 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
-17.2%
3Y
-27.9%
5Y
-42.4%
All
-59.0%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVO ER 25-100 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO ER 25-100 TAB, manufactured by American Health Packaging, is $0.1117 per EA (NDC 68084028101), effective Feb 25, 2026.
How has the price of CARBIDOPA-LEVO ER 25-100 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVO ER 25-100 TAB has declined 59.0%. It has been tracked across 640 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO ER 25-100 TAB?
Since Nov 28, 2013, the NADAC for CARBIDOPA-LEVO ER 25-100 TAB has ranged from a low of $0.1048 (Nov 20, 2024) to a high of $0.3892 (May 13, 2015), with a median of $0.2491 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVO ER 25-100 TAB?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBIDOPA-LEVODOPA 25-100 TAB, is $0.0766 per EA — about 31% below CARBIDOPA-LEVO ER 25-100 TAB.
Who manufactures CARBIDOPA-LEVO ER 25-100 TAB?
CARBIDOPA-LEVO ER 25-100 TAB (NDC 68084028101) is labeled by American Health Packaging, and CMS classifies it as a generic product.